Tsang Stephen H, Woodruff Michael L, Jun Lin, Mahajan Vinit, Yamashita Clyde K, Pedersen Robert, Lin Chyuan-Sheng, Goff Stephen P, Rosenberg Thomas, Larsen Michael, Farber Debora B, Nusinowitz Steven
Brown Glaucoma Laboratory, Center for Neurobiology and Behavior, Columbia University, New York, New York, USA.
Hum Mutat. 2007 Mar;28(3):243-54. doi: 10.1002/humu.20425.
Mutations in the beta-subunit of cGMP-phosphodiesterase (PDE6beta) can lead to either progressive retinal disease, such as human retinitis pigmentosa (RP), or stationary disease, such as congenital stationary night blindness (CSNB). Individuals with CSNB in the Rambusch pedigree were found to carry the H258N allele of PDE6B (MIM# 180072); a similar mutation was not found in RP patients. This report describes an individual carrying the H258N allele, who presented with generalized retinal dysfunction affecting the rod system and a locus of dysfunction at the rod-bipolar interface. Also described are preclinical studies in which transgenic mice with the H258N allele were generated to study the pathophysiological mechanisms of CSNB. While Pde6b(rd1)/Pde6b(rd1) mice have severe photoreceptor degeneration, as in human RP, the H258N transgene rescued these cells. The cGMP-PDE6 activity of dark-adapted H258N mice showed an approximate three-fold increase in the rate of retinal cGMP hydrolysis: from 130.1 nmol x min(-1) x nmol(-1) rhodopsin in wild-type controls to 319.2 nmol x min(-1) x nmol(-1) rhodopsin in mutants, consistent with the hypothesis that inhibition of the PDE6beta activity by the regulatory PDE6gamma subunit is blocked by this mutation. In the albino (B6CBA x FVB) F2 hybrid background, electroretinograms (ERG) from H258N mice were similar to those obtained from affected Rambusch family members, as well as humans with the most common form of CSNB (X-linked), demonstrating a selective loss of the b-wave with relatively normal a-waves. When the H258N allele was introduced into the DBA background, there was no evidence of selective reduction in b-wave amplitudes; rather a- and b-wave amplitudes were both reduced. Thus, factors other than the PDE6B mutation itself could contribute to the variance of an electrophysiological response. Therefore, caution is advisable when interpreting physiological phenotypes associated with the same allele on different genetic backgrounds. Nevertheless, such animals should be of considerable value in further studies of the molecular pathology of CSNB.
环磷酸鸟苷磷酸二酯酶(PDE6β)β亚基的突变可导致进行性视网膜疾病,如人类色素性视网膜炎(RP),或静止性疾病,如先天性静止性夜盲(CSNB)。在兰布施家族中患有CSNB的个体被发现携带PDE6B的H258N等位基因(MIM# 180072);在RP患者中未发现类似突变。本报告描述了一名携带H258N等位基因的个体,该个体表现出影响视杆系统的广泛性视网膜功能障碍以及视杆-双极细胞界面处的功能障碍位点。还描述了临床前研究,其中生成了携带H258N等位基因的转基因小鼠以研究CSNB的病理生理机制。虽然Pde6b(rd1)/Pde6b(rd1)小鼠像人类RP一样有严重的光感受器退化,但H258N转基因挽救了这些细胞。暗适应的H258N小鼠的环磷酸鸟苷磷酸二酯酶6(cGMP-PDE6)活性显示视网膜cGMP水解速率增加了约三倍:从野生型对照中视紫红质的130.1 nmol×min(-1)×nmol(-1)增加到突变体中视紫红质的319.2 nmol×min(-1)×nmol(-1),这与调节性PDE6γ亚基对PDE6β活性的抑制被该突变阻断的假设一致。在白化(B6CBA×FVB)F2杂交背景下,H258N小鼠的视网膜电图(ERG)与受影响的兰布施家族成员以及患有最常见形式CSNB(X连锁)的人类所获得的ERG相似,表现出b波选择性丧失而a波相对正常。当将H258N等位基因引入DBA背景时,没有证据表明b波振幅有选择性降低;相反,a波和b波振幅都降低了。因此,除了PDE6B突变本身之外的因素可能导致电生理反应的差异。因此,在解释不同遗传背景下与相同等位基因相关的生理表型时应谨慎。然而,此类动物在CSNB分子病理学的进一步研究中应具有相当大的价值。